To support medical researchers, policymakers, journalists and healthcare professionals in their efforts to better understand and combat coronavirus, now declared a global health emergency, an array of valuable Clarivate resources have been assembled.
Clarivate has proprietary data and insights spanning scientific and academic research, life sciences and intellectual property, which cover every stage of the fight against the coronavirus – from historical literature on all strains going back decades, to drug discovery and clinical development, regulatory submission, commercialisation and patents.
This resource center can help delve into the existing coronavirus drug research with 30 days of free access to the proprietary data in Cortellis Drug Discovery Intelligence, which is the broadest, deepest and most accurate source of R&D intelligence in one single platform. This includes data on drug pipelines, experimental pharmacology, pharmacokinetics, animal models, targets, patents and more; access a free, comprehensive ‘disease briefing’ on Coronaviruses; read the top free papers on the Wuhan strain of the Coronavirus, carefully selected and curated from Web of Science, the only publisher-neutral database for original scientific literature; and read the latest news and expert analysis on the coronavirus from BioWorld in real time as-it-happens. Coverage includes breaking research, clinical, regulatory and business development news, with archives on coronaviruses reaching back to 1991.
Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.Click here to read the original press release.